Oncogenic activation of c-Myb correlates with a loss of negative regulation by TIF1beta and Ski.

The c-myb proto-oncogene product (c-Myb) regulates proliferation of hematopoietic cells by inducing the transcription of a group of target genes. Removal or mutations of the negative regulatory domain (NRD) in the C-terminal half of c-Myb leads to increased transactivating capacity and oncogenic activation. Here we report that TIF1beta directly binds ...
to the NRD and negatively regulates the c-Myb-dependent trans-activation. In addition, three corepressors (Ski, N-CoR, and mSin3A) bind to the DNA-binding domain of c-Myb together with TIF1beta and recruit the histone deacetylase complex to c-Myb. Furthermore, the Drosophila TIF1beta homolog, Bonus, negatively regulates Drosophila Myb activity. The Ski corepressor competes with the coactivator CBP for binding to c-Myb, indicating that the selection of coactivators and corepressors is a key event for c-Myb-dependent transcription. Mutations or deletion of the NRD of c-Myb and the mutations found in the DNA-binding domain of v-Myb decrease the interaction with these corepressors and weaken the corepressor-induced negative regulation of Myb activity. These observations have conceptual implications for understanding how the nuclear oncogene is activated.
Mesh Terms:
Animals, DNA-Binding Proteins, Drosophila, Gene Expression Regulation, Neoplastic, Genes, myb, Mice, Mutation, Nuclear Proteins, Proto-Oncogene Proteins, Repressor Proteins, Transcription Factors, Transcriptional Activation
J. Biol. Chem.
Date: Apr. 16, 2004
Download Curated Data For This Publication
Switch View:
  • Interactions 21